
IDEXX Laboratories IDXX
€ 490.90
-1.25%
Geschäftsbericht 2025
hinzugefügt 20.02.2026
IDEXX Laboratories P/S 2011-2026 | IDXX
P/S Jährlich IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 | 9.66 | 13 | 12.7 | 14.1 | 16.4 | 10.2 | 8.15 | 8.32 | 6.09 | 4.05 | 5.34 | 4.39 | 4.09 | 3.95 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.4 | 3.95 | 8.82 |
P/S anderer Aktien in der Diagnostik & Forschung
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
6.64 | $ 111.16 | -2.04 % | $ 33.8 B | ||
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
4.09 | $ 13.26 | -2.07 % | $ 3.77 B | ||
|
Biodesix
BDSX
|
1.29 | $ 14.28 | -2.19 % | $ 1.85 B | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
0.279 | $ 1.14 | -1.3 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 16.25 | -12.16 % | $ 175 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
5.13 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 24.03 | -2.71 % | $ 667 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
1.92 | $ 158.22 | -4.18 % | $ 7.84 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 196.67 | -0.75 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
21.5 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.76 | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
1.47 | $ 8.45 | - | $ 33.7 M | ||
|
DexCom
DXCM
|
5.47 | $ 62.38 | -5.61 % | $ 24.3 B | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 15.72 | -4.06 % | $ 475 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
13.7 | $ 84.78 | -3.77 % | $ 10.6 B | ||
|
PerkinElmer
PKI
|
5.13 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 102.7 | -0.37 % | $ 8.47 B | ||
|
Illumina
ILMN
|
3.75 | $ 118.42 | -4.81 % | $ 18.8 B | ||
|
Interpace Biosciences
IDXG
|
0.0879 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
IQVIA Holdings
IQV
|
1.74 | $ 165.13 | -2.52 % | $ 28.4 B | ||
|
Lantheus Holdings
LNTH
|
3.32 | $ 74.66 | -2.23 % | $ 5.04 B | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
5.12 | $ 455.39 | -2.4 % | $ 13.1 B | ||
|
Mettler-Toledo International
MTD
|
7.06 | $ 1 240.08 | -2.36 % | $ 25.6 B | ||
|
Myriad Genetics
MYGN
|
0.496 | $ 4.43 | -4.22 % | $ 410 M | ||
|
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.7 | 2.4 % | $ 2.52 M | ||
|
NeoGenomics
NEO
|
2.04 | $ 7.55 | -2.77 % | $ 967 M | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 8.85 | -3.33 % | $ 1.92 B | ||
|
National Research Corporation
NRC
|
2.29 | $ 17.23 | -0.78 % | $ 386 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M |